Leibniz-Institute on Ageing - Fritz-Lipmann-Institute (FLI), Germany
Prof. Neri obtained PhD in Biotechnology in Siena (Italy) working on embryonic stem cells epigenetics. Then he worked as postdoc between Human Genetics Foundation (HuGeF) in Torino (Italy) and the Radboud University Medical Centre, Nijmegen (Netherlands) where specialized his research on the DNA methylation specific epigenetic mark on stem cell, differentiation and colon cancer. During this period, he characterized new mechanisms of gene transcriptional regulation, developed new epigenomic genome-wide methods and identified the role of the intragenic methylation. In 2015, Prof. Neri was appointed as Group Leader of the “Epigenetics research group” at the Fritz Lipmann Leibniz Institute on Aging (FLI) in Jena (Germany). His research was supported by the Sofja Kovalevskaja starting grant of the von Humboldt foundation, and it was focused on the aging-dependent epigenetic aberrations occurring in adult stem cells promoting colon cancer. In 2021, Prof. Neri moved his laboratory at the University of Torino, where he is Full Professor of Molecular Biology and is leading the research group of Epigenetics of Aging & Cancer at the Molecular Biotechnology Center (MBC) in Torino. The current research of Prof. Neri focuses on inflammaging, intestinal aging, epigenetic drifts and how aging functionally impacts on colon cancer initiation.